Read the latest WaveData articles, or search through our archive.

Follow us on LinkedIn to keep up to date with WaveData news, articles, insights and analysis

Please use complete words when searching…

What Price Triggers A Shortage? Part 3

What Price Triggers A Shortage? Part 3

Today we want to explore the low market prices which happen before a shortage begins, and try to work out when manufacturers should alter their forecasts. Looking at the low market prices which precede shortages, it does appear that the vast majority of these take place when the generic product is being sold to pharmacies for between 1% and 7% of the branded products’ reimbursement price.

read more
What Price Triggers a Shortage? Part 2

What Price Triggers a Shortage? Part 2

Today we want to look at these low guaranteed shortage inducing prices for larger groups of products and the first step is to find a way to compare products with widely differing prices. For example, the average market price of Irbesartan Tabs 75mg 28 is less than £1.00, whereas the market price of Famciclovir Tabs 500mg 14 is over £100.00. So, we can’t simply say that any price below £3.00 risks a shortage, because some products are easy and cheap to make and transport, and others more difficult and cost more. To put all products on a level footing we need to find a better way to describe this unprofitable (£1.64) point, so the supply chain can look out for it.

read more
What Price Triggers A Shortage?

What Price Triggers A Shortage?

Over the last few years, WaveData has repeatedly analysed shortages and concessions, trying to find links with market prices. The connection seems fairly obvious to us, with 24 years of historical market price data we have the luxury of having the right data to be able to analyse long term pricing and concessions side by side. We strongly believe that the primary triggers that cause shortages are based on two key factors.

read more
Is there a link between the number of monthly concessions and the amount of short dated stock on sale to pharmacies and dispensing doctors?

Is there a link between the number of monthly concessions and the amount of short dated stock on sale to pharmacies and dispensing doctors?

It seems relatively obvious to say that if there is a serious shortage there probably won’t be much stock of any form around, generic, brand, parallel import or short dated. This probably means that any short dated stock that was in the supply chain, even with very little time left before expiry, will be used up very quickly when there’s a major shortage.

read more
Pregabalin Prices Hotting Up

Pregabalin Prices Hotting Up

Finally, it really does feel like Summer. Looking out of the window at WaveData HQ the sky is blue and the sun is shining. It will be ice creams all round at lunch time today! It’s not just the temperature that's hotting up….. Dave Wallace at The Generics Bulletin...

read more
Olanzapine 10mg 28 – one to watch

Olanzapine 10mg 28 – one to watch

Whilst researching for the June edition of WaveData’s Bulletin, Editor Jackie Moss flagged up Olanzapine Tabs 10mg 28 as one to watch. After a reasonably long period of stability, with the average price not exceeding £0.80 since April 2022, we have seen a month on...

read more
Salbutamol Nebuliser Liquid Unit Dose Vials 2.5mg/2.5ml 20 shortage hits hospitals, pharmacies, and surgeries

Salbutamol Nebuliser Liquid Unit Dose Vials 2.5mg/2.5ml 20 shortage hits hospitals, pharmacies, and surgeries

Hospitals have been advised to place urgent orders and not wait for supplies to be exhausted. There is no real alternative to Salbutamol and it’s a critical part of daily medicine and risks serious harm to patience if supply issues are not resolved quickly. The 2.5 mg pack of this critical medicine has been available for just under £2 for a very long period of at least 10 years. However, between June 2017 and July 2018 the average market price fell to £1.40. At this point manufacturers may have decided that this product was not profitable in the long-term and withdrew some of their manufacturing capability.

read more
ADHD Drug Shortages and Methylphenidate long term price trends

ADHD Drug Shortages and Methylphenidate long term price trends

An increase in global demand due to a rapid rise in the number of ADHD diagnoses, manufacturing issues and delays in distribution are the main reasons for the shortages, say the DHSC. But, what about profitability? Is the market still attractive and generating enough profit for manufacturers to encourage them to compete? Charles Joynson, WaveData MD, investigates the long term price trends of Methylphenidate Tabs 10mg 30s.

read more